Bausch + Lomb Corp

BLCONYSE · USD
16.85USD0.00 (+0.48%)
679

Bausch + Lomb Corp (BLCO) Wheel Strategy

BLCO wheel strategy scan found 8 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 58.8%.

Read more

Running a BLCO wheel strategy lets you generate consistent premium income on Bausch + Lomb Corp while setting your own entry and exit prices on the underlying. Bausch + Lomb Corp's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own BLCO, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best BLCO wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on BLCO, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable BLCO wheel from a losing one.

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use.

The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the BLCO wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your BLCO wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Nov 20, 202616.00$0.10$1.65-0.37640%97.9%58.8%10
Feb 19, 202717.00$0.90$2.90-0.411550%52.3%40.2%1
Feb 19, 202716.00$0.45$2.28-0.361550%93.8%33.5%1
May 21, 202716.00$0.05$2.48-0.352460%92.0%23.0%0
May 21, 202717.00$0.10$2.50-0.412460%59.0%21.8%0
Feb 19, 202714.00$0.05$0.95-0.231550%100.0%16.0%1
Dec 18, 202615.00$0.15$0.55-0.24920%100.0%14.5%117
Feb 19, 202715.00$0.20$0.75-0.261550%99.9%11.8%1

As of September 18, 2026

Run the Wheel on BLCO With Confidence

Find the best BLCO wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial